Short-term efficacy of sublingual immunotherapy in patients with allergic rhinitis of all ages
10.3760/cma.j.cn341190-20221014-00803
- VernacularTitle:舌下免疫治疗各年龄段变应性鼻炎患者的短期疗效分析
- Author:
Xuan TANG
1
;
Lixin YANG
;
Donghai LI
Author Information
1. 蚌埠市第三人民医院耳鼻喉科，蚌埠 233000
- Keywords:
Rhinitis, Allergic, perennial;
Sublingual immunotherapy;
Age distribution;
Comparative effectiveness research;
Mite infestations
- From:
Chinese Journal of Primary Medicine and Pharmacy
2022;29(12):1859-1861
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the short-term efficacy of sublingual immunotherapy in patients with allergic rhinitis of all ages.Methods:The data of 230 patients with allergic rhinitis of all ages who received sublingual immunotherapy in The Third People's Hospital of Bengbu from November 2020 to September 2021 were included in this study. Patient distribution characteristics were analyzed. Ninety-three patients were randomly selected and divided into child, adolescent, and adult groups according to different ages. Total nasal symptom scores measured before and 4 months after sublingual immunotherapy were compared among patients of different ages to evaluate the short-term efficacy of sublingual immunotherapy. The skin prick test was used to determine the allergic state of patients. Change in total nasal symptom score after treatment relative to that before treatment was used to evaluate the efficacy of sublingual immunotherapy.Results:The age range of patients receiving sublingual immunotherapy was large (3-71 years), but the average age was only 17.70 years. Ninety-three patients were followed up, including 50 children and 43 adolescents or adults. After 4 months of sublingual immunotherapy, total nasal symptom score in children and adolescents or adults were significantly decreased compared with those before treatment [(3.66 ± 1.69) points vs. (6.60 ± 1.96) points, (3.49 ± 1.72) points vs. (6.28 ± 2.28) points, both P < 0.001]. Before and after treatment, there was no significant difference in total nasal symptom score between children and adolescents or adults (both P > 0.05). Conclusion:Patients with allergic rhinitis who receive sublingual immunotherapy tend to be young. Short-term sublingual immunotherapy is effective for allergic rhinitis. There is no remarkable difference in the efficacy of sublingual immunotherapy between patients with allergic rhinitis of all ages.
